首页> 美国卫生研究院文献>Tissue Engineering. Part B Reviews >In Situ Tissue Regeneration: Chemoattractants for Endogenous Stem Cell Recruitment
【2h】

In Situ Tissue Regeneration: Chemoattractants for Endogenous Stem Cell Recruitment

机译:原位组织再生:内源性干细胞招募趋化剂。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tissue engineering uses cells, signaling molecules, and/or biomaterials to regenerate injured or diseased tissues. Ex vivo expanded mesenchymal stem cells (MSC) have long been a cornerstone of regeneration therapies; however, drawbacks that include altered signaling responses and reduced homing capacity have prompted investigation of regeneration based on endogenous MSC recruitment. Recent successful proof-of-concept studies have further motivated endogenous MSC recruitment-based approaches. Stem cell migration is required for morphogenesis and organogenesis during development and for tissue maintenance and injury repair in adults. A biomimetic approach to in situ tissue regeneration by endogenous MSC requires the orchestration of three main stages: MSC recruitment, MSC differentiation, and neotissue maturation. The first stage must result in recruitment of a sufficient number of MSC, capable of effecting regeneration, to the injured or diseased tissue. One of the challenges for engineering endogenous MSC recruitment is the selection of effective chemoattractant(s). The objective of this review is to synthesize and evaluate evidence of recruitment efficacy by reported chemoattractants, including growth factors, chemokines, and other more recently appreciated MSC chemoattractants. The influence of MSC tissue sources, cell culture methods, and the in vitro and in vivo environments is discussed. This growing body of knowledge will serve as a basis for the rational design of regenerative therapies based on endogenous MSC recruitment. Successful endogenous MSC recruitment is the first step of successful tissue regeneration
机译:组织工程学使用细胞,信号分子和/或生物材料来再生受伤或患病的组织。体外扩增的间充质干细胞(MSC)长期以来一直是再生疗法的基石。然而,包括改变的信号响应和降低的归巢能力的缺点已经促使基于内源性MSC募集的再生研究。最近成功的概念验证研究进一步推动了基于内源性MSC募集的方法。干细胞的迁移是发育过程中形态发生和器官发生以及成人组织维护和损伤修复所必需的。内源性MSC通过仿生方法原位组织再生需要编排三个主要阶段:MSC募集,MSC分化和新组织成熟。第一阶段必须导致将足够数量的能够再生的MSC募集到受伤或患病的组织中。工程内源性MSC募集的挑战之一是选择有效的化学引诱剂。这篇综述的目的是通过报告的趋化因子,包括生长因子,趋化因子和其他最近被赞赏的MSC趋化因子,来合成和评估招募功效的证据。讨论了MSC组织来源,细胞培养方法以及体外和体内环境的影响。不断增长的知识将为基于内源性MSC募集的合理设计再生疗法提供基础。成功的内源性MSC募集是成功组织再生的第一步

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号